7,653
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?

ORCID Icon, , , , , , , & show all
Article: 2160928 | Received 30 Apr 2022, Accepted 09 Dec 2022, Published online: 28 Dec 2022

References

  • Abdulkareem, I.H. and Zurmi, I.B., 2012. Review of hormonal treatment of breast cancer. Nigerian Journal of Clinical Practice, 15 (1), 1–6.
  • ACOG committee opinion No. 336. 2006. Tamoxifen and uterine cancer. Obstet Gynecol, 107 (6), 1475–1478.
  • ACOG Committee Opinion No 426. 2009. The role of transvaginal ultrasonography in the evaluation of postmenopausal bleeding. Obstet Gynecol, 113 (2 Pt 1), 462–464.
  • Aedo, S., et al., 2008a. Incidencia de cáncer endometrial en mujeres menopáusicas con sospecha clínica de patología en el endometrio. Rev Obstet Ginecol Hosp Santiago Oriente Dr Luis Tisné Brousse, 3 (1), 9–14.
  • Aedo, S., et al., 2008b. Utilidad de la edad e índice de masa corporal en el diagnóstico de cáncer endometrial en la mujer menopáusica. Rev Obstet Ginecol Hosp Santiago Oriente Dr Luis Tisné Brousse, 3 (2), 99–106.
  • Aedo, S., et al., 2010. Valor del grosor endometrial ultrasonográfico dado la edad y metrorragia en el diagnóstico de cáncer de endometrio. Rev Obstet Ginecol Hosp Santiago Oriente Dr Luis Tisné Brousse, 5 (1), 17–22.
  • Antunes, A., Jr., et al., 2007. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy. Maturitas, 57 (4), 415–421.
  • Bachmann, L., et al., 2003. Probability analysis for diagnosis of endometrial hyperplasia and cancer in postmenopausal bleeding: an approach for a rational diagnostic workup. Acta obstetricia et gynecologica Scandinavica, 82 (6), 564–569.
  • Baiocchi, G., et al., 2009. Malignancy in endometrial polyps: a 12-year experience. American Journal of Obstetrics and Gynecology, 201 (5), 462 e1-4–462.e4.
  • Bakour, S.H., Khan, K.S. and Gupta, J.K., 2000. The risk of premalignant and malignant pathology in endometrial polyps. Acta obstetricia et gynecologica Scandinavica, 79 (4), 317–320.
  • Berliere, M., et al., 2000. Identification of women at high risk of developing endometrial cancer on tamoxifen. European Journal of Cancer, 36 (Suppl 4), S35–S36.
  • Ciatto, S., et al., 1995. A feasibility study of screening for endometrial carcinoma in postmenopausal women by ultrasonography. Tumori, 81 (5), 334–337.
  • Cuzick, J., et al., 2013. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet, 381 (9880), 1827–1834.
  • Domíngues, A.P., et al., 2009. Endometrial polyps in postmenopausal women. Acta obstetricia et gynecologica Scandinavica, 88 (5), 618–620.
  • Famuyide, A., et al., 2014. Asymptomatic thickened endometrium in postmenopausal women: malignancy risk. Journal of Minimally Invasive Gynecology, 21 (5), 782–786.
  • Fernández-Parra, J., et al., 2006. Hysteroscopic evaluation of endometrial polyps. International Journal of Gynaecology and Obstetrics, 95 (2), 144–148.
  • Ferrazzi, E., et al., 2009. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. American Journal of Obstetrics and Gynecology, 200 (3), 235.e1–235-e6.
  • Fishman, M., et al., 2006. Changes in the sonographic appearance of the uterus after discontinuation of tamoxifen therapy. Journal of Ultrasound in Medicine, 25 (4), 469–473.
  • Fleischer, A., et al., 2001. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. American Journal of Obstetrics and Gynecology, 184 (2), 70–75.
  • Gambacciani, M., et al., 2004. Clinical usefulness of endometrial screening by ultrasound in asymptomatic postmenopausal women. Maturitas, 48 (4), 421–424.
  • Gerber, B., et al., 2001. Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding. European Journal of Cancer, 37 (1), 64–71.
  • Ghoubara, A., et al., 2018. Thickened endometrium in asymptomatic postmenopausal women – determining an optimum threshold for prediction of atypical hyperplasia and cancer. Journal of Obstetrics and Gynaecology, 38 (8), 1146–1149.
  • Giannella, L., et al., 2014. Diagnostic accuracy of endometrial thickness for the detection of intra-uterine pathologies and appropriateness of performed hysteroscopies among asymptomatic postmenopausal women. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 177, 29–33.
  • Goldstein, R.B., et al., 2001. Evaluation of the woman with postmenopausal bleeding: society of radiologists in ultrasound-sponsored consensus conference statement. Journal of Ultrasound in Medicine, 20 (10), 1025–1036.
  • Goldstein, S.R., 2010. Modern evaluation of the endometrium. Obstetrics & Gynecology, 116 (1), 168–176.
  • Gregoriou, O., et al., 2009. Clinical parameters linked with malignancy in endometrial polyps. Climacteric, 12 (5), 454–458.
  • Linkov, F., et al., 2008. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. European Journal of Cancer, 44 (12), 1632–1644.
  • Machado, F., et al., 2005. Tamoxifen and endometrial cancer. Is screening necessary? A review of the literature. European Journal of Gynaecological Oncology, 26 (3), 257–265.
  • National Institute for Health and Care Excellence (NICE). 2016. Suspected cancer: recognition and referral NICE guidelines NG12. Available from: https://www.rcog.org.uk [Accessed 5 Dec 2017].
  • OMS. 1996. Investigaciones sobre la menopausia en los años noventa: Informe de un grupo científico de la OMS. OMS (Serie de informes técnicos n° 866).
  • Opolskiene, G., Sladkevicius, P. and Valentin, L., 2007. Ultrasound assessment of endometrial morphology and vascularity to predict endometrial malignancy in women with postmenopausal bleeding and sonographic endometrial thickness > or= 4.5 mm. Ultrasound in Obstetrics & Gynecology, 30 (3), 332–340.
  • Saatli, B., et al., 2014. The role of endometrial thickness for detecting endometrial pathologies in asymptomatic postmenopausal women. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 54 (1), 36–40.
  • Savelli, L., et al., 2003. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. American Journal of Obstetrics and Gynecology, 188 (4), 927–931.
  • Schmidt, D., 2006. Changes in the endometrium after tamoxifen therapy. Der Pathologe, 27 (1), 27–32.
  • Schmidt, T., et al., 2009. Hysteroscopy for asymptomatic postmenopausal women with sonographically thickened endometrium. Maturitas, 62 (2), 176–178.
  • Smith, P., et al., 2014. Recurrent postmenopausal bleeding: a prospective cohort study. Journal of Minimally Invasive Gynecology, 21 (5), 799–803.
  • Smith, R.A., Cokkinides, V. and Brawley, O.W., 2008. Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues. A Cancer Journal for Clinicians, 58 (3), 161–179.
  • Smith-Bindman, R., et al., 1998. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. Jama, 280 (17), 1510–1517.
  • Sócrates Aedo, M., et al., 2013. Engrosamiento endometrial asintomático, artículo de revisión. Reviews in Obstetrics and Gynecology – Hosp. Santiago Oriente Dr. Luis Tisné Brousse 8 (2), 80–87.
  • Tjarks, M. and Van Voorhis, B.J., 2000. Treatment of endometrial polyps. Obstetrics and Gynecology, 96 (6), 886–889.
  • Tsuda, H., et al., 2005. Transvaginal ultrasonography of the endometrium in postmenopausal Japanese women. Gynecologic and Obstetric Investigation, 60 (4), 218–223.
  • Wolfman, W., et al., 2010. Asymptomatic Endometrial Thickening. Journal of Obstetrics and Gynaecology Canada, 32 (10), 990–999.
  • Yasa, C., et al., 2016. Evaluation of the diagnostic role of transvaginal ultrasound measurements of endometrial thickness to detect endometrial malignancy in asymptomatic postmenopausal women. Archives of Gynecology and Obstetrics, 294 (2), 311–316.